Follow
Ramlah Kadir
Title
Cited by
Cited by
Year
Proteoliposomes from Mycobacterium smegmatis induce immune cross-reactivity against Mycobacterium tuberculosis antigens in mice
L Rodriguez, Y Tirado, F Reyes, A Puig, R Kadir, R Borrero, S Fernandez, ...
Vaccine 29 (37), 6236-6241, 2011
362011
Immunogenicity and cross-reactivity against Mycobacterium tuberculosis of proteoliposomes derived from Mycobacterium bovis BCG
F Reyes, Y Tirado, A Puig, R Borrero, G Reyes, S Fernández, JL Pérez, ...
BMC immunology 14 (1), 1-5, 2013
172013
Evaluation of specific humoral immune response and cross reactivity against Mycobacterium tuberculosis antigens induced in mice immunized with liposomes composed of total …
M de los Angeles García, R Borrero, R Marrón, ME Lanio, L Canet, ...
BMC immunology 14 (1), 1-5, 2013
162013
Evaluation of the humoral immune response and cross reactivity against Mycobacterium tuberculosis of mice immunized with liposomes containing glycolipids of Mycobacterium smegmatis
R Borrero, MA García, L Canet, C Zayas, F Reyes, JL Prieto, JF Infante, ...
BMC immunology 14 (1), 1-4, 2013
162013
Mycobacterium smegmatis proteoliposome induce protection in a murine progressive pulmonary tuberculosis model
Y Tirado, A Puig, N Alvarez, R Borrero, A Aguilar, F Camacho, F Reyes, ...
Tuberculosis 101, 44-48, 2016
62016
Specific and cross-reactive immune response against Mycobacterium tuberculosis antigens in mice immunized with proteoliposomes from Mycobacterium bovis BCG
N Alvarez, D Serpa, R Kadir, Y Tirado, R Borrero, S Fernández, ...
Asian Pacific Journal of Tropical Biomedicine 7 (3), 188-192, 2017
52017
Adipose-Derived Stem Cell:“Treat or Trick”
SS Airuddin, AS Halim, WA Wan Sulaiman, R Kadir, NAM Nasir
Biomedicines 9 (11), 1624, 2021
42021
TB VACCINES BASED ON PROTEOLIPOSOMES AND LIPOSOMES FROM NON PATHOGENIC MYCOBACTERIA
A Acosta, NM Nor, A Puig, R Kadir, F Reyes, MM Hossain, Y Tirado, ...
The art & science of tuberculosis vaccine development, 783-793, 2014
22014
Nanoparticles for the treatment of glaucoma-associated neuroinflammation
L Lambuk, NAA Suhaimi, MZ Sadikan, AJA Jafri, S Ahmad, NAA Nasir, ...
Eye and Vision 9 (1), 1-29, 2022
2022
Liposomes in the prophylaxis and treatment of infectious diseases
ASN Azlyna, S Ahmad, SMN Husna, ME Sarmiento, A Acosta, ...
Life Sciences, 120734, 2022
2022
Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma
L Lambuk, S Ahmad, MZ Sadikan, NA Nordin, R Kadir, NAA Nasir, ...
Frontiers in Immunology, 2240, 2022
2022
Liposomes as immunological adjuvants and delivery systems in the development of tuberculosis vaccine: A review
NEM Luwi, S Ahmad, ASN Azlyna, A Nordin, ME Sarmiento, A Acosta, ...
Asian Pacific Journal of Tropical Medicine 15 (1), 7, 2022
2022
Profile of TNFR2 (+) Tregs and CD103 (+) DCs in the exposure of gold nanoparticles and etanercept in PBMCs of asthma patients
SB Ahmad, NA Azid, R Kadir, JK Lim, R Mohamud
ALLERGY 75, 325-326, 2020
2020
Liposomes derived from Mycobacterium smegmatis promote immune activation of mice bone marrow-derived dendritic cells
NEM Luwi, R Kadir, R Mohamud, M de los A Garcia-Santana, R Acevedo, ...
International journal of mycobacteriology 9 (3), 261, 2020
2020
Effects of Gold Nanoparticles and Etanercept on the Expression of TNFR2 Expressing Regulatory T cells and CD103+ Dendritic Cells on Human PBMC in …
S Ahmad, NA Azid, R Kadir, LJ Kang, R Mohamud
The Malaysian Journal of Medical Sciences 27, 5-5, 2020
2020
Proteoliposomes from Mycobacterium Bovis BCG and Mycobacterium Smegmatis as New Vaccine Candidates Against Tuberculosis
R Kadir
Universiti Sains Malaysia, 2016
2016
The Trace
A Acosta, NM Nor, A Puig, R Kadir, F Reyes, MM Hossain, Y Tirado, ...
The system can't perform the operation now. Try again later.
Articles 1–17